Fenistil Ampoules
Recall
|
Medicines
|
11/07/2013
The marketing authorization holder informed its supplied customers in a letter dated July 9, 2013, that in the course of quality assurance measures it was determined that in batch 1200758 isolated ampoules with yellowish discolored contents and thus a possible reduced active ingredient content were observed. Other batches of this product are not affected by this quality defect.
Name of the medicinal product | Fenistil - Ampullen |
---|---|
Marketing authorisation number(s) | 1-19861 |
Marketing authorisation holder | Novartis Consumer Health - Gebro GmbH |
Batch number(s) | 1200758 |
Classification of the recall | 2 |
BASG reference number | INS-640.001-0821 |
Further inquiry note
Page last modified:
12/07/2022